BSYI Stock Price, Chart, Stats & News

229.03K
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

BioSyntech, Inc. develops biotherapeutic thermogels for tissue repair and therapeutic delivery. Its lead products in development include BST-CarGel, a biodegradable gel for cartilage repair; BST-InPod for heel pain relief; BST-DermOn for chronic wound healing; BST-Ossifil for bone filling; BST-Ossifix for bone structural support; and BST-Disc for intervertebral disc restoration. The company's products also comprise BST-Gel-based injectable products that deliver biotherapeutics to their targeted site of action; Arthro-BST, an arthroscopic device used for the non-destructive evaluation of cartilage degradation and/or repair; and Mach-1, a micromechanical testing system for evaluating the mechanical properties of tissues and materials.

Similar securities

Based on sector and market capitalization

Let's talk cookies

We use cookies to keep things running smoothly, tailor your experience, and optimize site performance. Accepting them means your experience will be a bit sweeter (and faster).

Report issue